Lipidor AB Logo

Lipidor AB

A former developer of topical skin medications using a spray platform; filed for bankruptcy.

LIPI | ST

Overview

Corporate Details

ISIN(s):
SE0012558617 (+1 more)
LEI:
549300OC9DDXCE1GMX60
Country:
Sweden
Address:
C/O Ekonomistubben AB, 102 16 Stockholm

Description

Lipidor AB was a pharmaceutical development company focused on topical medications for skin diseases. The company's core was its proprietary AKVANO technology, a water-free, lipid-based, sprayable drug delivery platform. This technology was designed to enhance the delivery of active pharmaceutical ingredients for treating conditions such as psoriasis, acne vulgaris, and bacterial skin infections, while offering a convenient alternative to traditional creams and ointments. The company's pipeline included product candidates that had reached late-stage clinical development, such as AKP02 for the treatment of psoriasis. In May 2025, the company filed for bankruptcy.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Lipidor AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Lipidor AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Lipidor AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

ARTELO BIOSCIENCES, INC. Logo
Clinical-stage biopharma developing therapeutics by modulating the endocannabinoid system.
United States of America
ARTL
Ascelia Pharma Logo
Biotechnology company developing and commercializing novel drugs for orphan oncology.
Sweden
ACE
Ascendis Pharma A/S Logo
Biopharmaceutical firm using its prodrug technology to treat rare diseases.
United States of America
ASND
ASCENTAGE PHARMA GROUP INTERNATIONAL Logo
A clinical-stage biopharma developing novel therapies for cancer and other diseases.
United States of America
AAPG
Specializes in hormone-related pharmaceuticals for internal medicine, OB/GYN, and urology.
Japan
4886
Aspire Biopharma Holdings, Inc. Logo
Develops sublingual drug delivery technologies for needle-free medications.
United States of America
ASBP
ASSEMBLY BIOSCIENCES, INC. Logo
A clinical-stage biotech developing small molecule antiviral therapeutics for viral diseases.
United States of America
ASMB
Assertio Holdings, Inc. Logo
Pharmaceutical company managing branded products for neurology and orphan diseases.
United States of America
ASRT
Astellas Pharma Inc. Logo
A global pharmaceutical company turning innovative science into value for patients.
Japan
4503
AstraZeneca PLC Logo
A global, science-led biopharmaceutical company developing prescription medicines.
United Kingdom
AZN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.